TD Cowen raised the firm’s price target on Option Care Health (OPCH) to $37 from $27 and keeps a Hold rating on the shares as part of a Q4 earnings preview. The firm says October and November drug trends remain positive for pharmacy benefit mangers and pharmacies.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health price target raised to $42 from $38 at Barrington
- Option Care Health: Resilient Core Growth, Structural Tailwinds, and Capital Allocation Support Buy Rating
- Option Care Health price target raised to $38 from $36 at Citizens
- Closing Bell Movers: Revvity up 9% on strong outlook
- Option Care Health Issues 2025 Results and 2026 Outlook